2021 ESC/EACTS Guidelines for the management of valvular heart disease.
Alec Vahanian,Friedhelm Beyersdorf,Fabien Praz,Milan Milojevic,Stephan Baldus,Johann Bauersachs,Davide Capodanno,Lenard Conradi,Michele De Bonis,Ruggero De Paulis,Victoria Delgado,Nick Freemantle,Martine Gilard,Kristina H. Haugaa,Anders Jeppsson,Peter Jüni,Luc Pierard,Bernard Prendergast,J. Rafael Sadaba,Christophe Tribouilloy,Wojtek Wojakowski +20 more
About:
This article is published in European Journal of Cardio-Thoracic Surgery.The article was published on 2021-10-22 and is currently open access. It has received 264 citations till now. The article focuses on the topics: Tricuspid Valve Insufficiency & Mitral valve stenosis.read more
Citations
More filters
Journal ArticleDOI
Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation
TL;DR: In this article , a 2-year end point was a composite of reoperation for tricuspid regurgitation, progression by two grades from baseline or the presence of severe tricusid reguritation, or death.
Journal ArticleDOI
Cardiac MR: From Theory to Practice
Tevfik F Ismail,Wendy Strugnell,C. Coletti,Maša Božić-Iven,Sebastian Weingärtner,Kerstin Hammernik,Teresa Correia,Thomas Küstner +7 more
TL;DR: An overview of novel deep learning image segmentation and analysis methods is provided with a focus on automatic, fast and reliable extraction of biomarkers and parameters of clinical relevance.
Journal ArticleDOI
Transcatheter Tricuspid Valve Therapy: From Anatomy to Intervention
Valeria Cammalleri,Myriam Carpenito,Maria Caterina Bono,Simona Mega,Gian Paolo Ussia,Francesco Grigioni +5 more
Journal ArticleDOI
Clinical Comparison of a Novel Balloon-Expandable Versus a Self-Expanding Transcatheter Heart Valve for the Treatment of Patients with Severe Aortic Valve Stenosis: The EVAL Registry
TL;DR: In this paper , a single-center, retrospective cohort analysis was performed with andnbsp;166 consecutive patients undergoing TAVR from March 2019 to March 2021 for severe symptomatic AS treated with either the balloon-expandable (BE) Sapien/XT THV vs. a self-expanding (SE) THV.
Journal ArticleDOI
Predictors of optimal procedural result after transcatheter edge‐to‐edge mitral valve repair in secondary mitral regurgitation
Marianna Adamo,Matteo Pagnesi,Antonio Popolo Rubbio,Luca Branca,Carmelo Grasso,Paolo Denti,Arturo Giordano,Maurizio Tusa,Federico De Marco,Laura Lupi,Antonio L. Bartorelli,Cosmo Godino,Rodolfo Citro,Francesco De Felice,Annalisa Mongiardo,Ida Monteforte,Emmanuel Villa,Cristina Giannini,Luca Testa,Salvatore Curello,Giuseppe Tarantini,Corrado Tamburino,Francesco Bedogni,Marco Metra +23 more
TL;DR: Procedural success after transcatheter edge‐to‐edge mitral valve repair (TEER) is defined as a reduction of mitral regurgitation (MR) degree to the lowest level possible.
References
More filters
Journal ArticleDOI
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski,Adriaan A. Voors,Stefan D. Anker,Héctor Bueno,John G.F. Cleland,Andrew J.S. Coats,Volkmar Falk,José Ramón González-Juanatey,Veli-Pekka Harjola,Ewa A. Jankowska,Mariell Jessup,Cecilia Linde,Petros Nihoyannopoulos,John Parissis,Burkert Pieske,Jillian P. Riley,Giuseppe M.C. Rosano,Luis M. Ruilope,Frank Ruschitzka,Frans H. Rutten,Peter van der Meer,Gerasimos Filippatos,John J.V. McMurray,Victor Aboyans,Stephan Achenbach,Stefan Agewall,Nawwar Al-Attar,John Atherton,Johann Bauersachs,A. John Camm,Scipione Carerj,Claudio Ceconi,Antonio Coca,Perry M. Elliott,Çetin Erol,Justin A. Ezekowitz,Covadonga Fernández-Golfín,Donna Fitzsimons,Marco Guazzi,Maxime Guenoun,Gerd Hasenfuss,Gerhard Hindricks,Arno W. Hoes,Bernard Iung,Tiny Jaarsma,Paulus Kirchhof,Juhani Knuuti,Philippe Kolh,Stavros Konstantinides,Mitja Lainscak,Patrizio Lancellotti,Gregory Y.H. Lip,Francesco Maisano,Christian Mueller,Mark C. Petrie,Massimo F Piepoli,Silvia G. Priori,Adam Torbicki,Hiroyuki Tsutsui,Dirk J. van Veldhuisen,Stephan Windecker,Clyde W. Yancy,José Luis Zamorano +62 more
TL;DR: Authors/Task Force Members: Piotr Ponikowski* (Chairperson) (Poland), Adriaan A. Voors* (Co-Chair person) (The Netherlands), Stefan D. Anker (Germany), Héctor Bueno (Spain), John G. F. Cleland (UK), Andrew J. S. Coats (UK)
Journal ArticleDOI
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
Roberto M. Lang,Luigi P. Badano,Victor Mor-Avi,Jonathan Afilalo,Anderson C. Armstrong,Laura Ernande,Frank A. Flachskampf,Elyse Foster,Steven A. Goldstein,Tatiana Kuznetsova,Patrizio Lancellotti,Denisa Muraru,Michael H. Picard,Ernst Rietzschel,Lawrence G. Rudski,Kirk T. Spencer,Wendy Tsang,Jens-Uwe Voigt +17 more
TL;DR: This document provides updated normal values for all four cardiac chambers, including three-dimensional echocardiography and myocardial deformation, when possible, on the basis of considerably larger numbers of normal subjects, compiled from multiple databases.
Journal ArticleDOI
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski,Adriaan A. Voors,Stefan D. Anker,Héctor Bueno,John G.F. Cleland,Andrew J.S. Coats,Volkmar Falk,José Ramón González-Juanatey,Veli-Pekka Harjola,Ewa A. Jankowska,Mariell Jessup,Cecilia Linde,Petros Nihoyannopoulos,John Parissis,Burkert Pieske,Jillian P. Riley,Giuseppe M.C. Rosano,Luis M. Ruilope,Frank Ruschitzka,Frans H. Rutten,Peter van der Meer +20 more
TL;DR: ACCF/AHAIAI: angiotensin-converting enzyme inhibitor as discussed by the authors, angio-catabolizing enzyme inhibitor inhibitor inhibitor (ACS inhibitor) is a drug that is used to prevent atrial fibrillation.
Journal ArticleDOI
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
Martin B. Leon,Craig R. Smith,Michael J. Mack,D. Craig Miller,Jeffrey W. Moses,Lars G. Svensson,E. Murat Tuzcu,John G. Webb,Gregory P. Fontana,Raj Makkar,David L. Brown,Peter C. Block,Robert A. Guyton,Augusto D. Pichard,Joseph E. Bavaria,Howard C. Herrmann,Pamela S. Douglas,John L. Petersen,Jodi J. Akin,William N. Anderson,Duolao Wang,Stuart J. Pocock +21 more
TL;DR: In patients with severe aortic stenosis who were not suitable candidates for surgery, TAVI, as compared with standard therapy, significantly reduced the rates of death from any cause, the composite end point of deathFrom any cause or repeat hospitalization, and cardiac symptoms, despite the higher incidence of major strokes and major vascular events.
Journal ArticleDOI
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
Craig R. Smith,Martin B. Leon,Michael J. Mack,D. Craig Miller,Jeffrey W. Moses,Lars G. Svensson,E. Murat Tuzcu,John G. Webb,Gregory P. Fontana,Raj Makkar,Mathew R. Williams,Todd M. Dewey,Samir R. Kapadia,Vasilis Babaliaros,Vinod H. Thourani,Paul J. Corso,Augusto D. Pichard,Joseph E. Bavaria,Howard C. Herrmann,Jodi J. Akin,William N. Anderson,Duolao Wang,Stuart J. Pocock +22 more
TL;DR: In high-risk patients with severe aortic stenosis, transcatheter and surgical procedures for aorti-valve replacement were associated with similar rates of survival at 1 year, although there were important differences in periprocedural risks.